Immune checkpoints bone marrow expression as the predictor of clinical outcome in myelodysplastic syndrome

AIMS: In our single-center retrospective study we evaluated whether level of different checkpoint molecules in bone marrow biopsies at diagnosis affect the clinical course of patients with myelodysplastic syndrome (MDS). METHODS AND RESULTS: A consecutive cohort of 55 MDS patients treated in our cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tcvetkov, Nikolai, Gusak, Artem, Morozova, Elena, Moiseev, Ivan, Baykov, Vadim, Barabanshikova, Maria, Lepik, Kirill, Bakin, Evgenyi, Vlasova, Julia, Osipova, Anna, Zubarovskaya, Ludmila, Afanasyev, Boris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364161/
https://www.ncbi.nlm.nih.gov/pubmed/32695574
http://dx.doi.org/10.1016/j.lrr.2020.100215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364161/
https://www.ncbi.nlm.nih.gov/pubmed/32695574
http://dx.doi.org/10.1016/j.lrr.2020.100215

Ejemplares similares